390 related articles for article (PubMed ID: 33633739)
1. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.
de Wit NM; Mol K; Rodríguez-Lorenzo S; de Vries HE; Kooij G
Front Immunol; 2020; 11():620348. PubMed ID: 33633739
[TBL] [Abstract][Full Text] [Related]
2. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
3. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
5. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
6. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.
Ma QL; Zhu C; Morselli M; Su T; Pelligrini M; Lu Z; Jones M; Denver P; Castro D; Gu X; Relampagos F; Caoili K; Teter B; Frautschy SA; Cole GM
Front Immunol; 2020; 11():558036. PubMed ID: 33178186
[TBL] [Abstract][Full Text] [Related]
7. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.
Podbielska M; Krotkiewski H; Hogan EL
Neurochem Res; 2012 Jun; 37(6):1154-69. PubMed ID: 22451227
[TBL] [Abstract][Full Text] [Related]
8. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders.
Ponce J; Ulu A; Hanson C; Cameron-Smith E; Bertoni J; Wuebker J; Fisher A; Siu KC; Marmelat V; Adamec J; Bhatti D
Front Aging Neurosci; 2022; 14():780811. PubMed ID: 35250536
[TBL] [Abstract][Full Text] [Related]
9. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.
Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP
Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025
[TBL] [Abstract][Full Text] [Related]
10. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.
Taha TA; Mullen TD; Obeid LM
Biochim Biophys Acta; 2006 Dec; 1758(12):2027-36. PubMed ID: 17161984
[TBL] [Abstract][Full Text] [Related]
11. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
14. Is autophagy the key mechanism by which the sphingolipid rheostat controls the cell fate decision?
Lavieu G; Scarlatti F; Sala G; Levade T; Ghidoni R; Botti J; Codogno P
Autophagy; 2007; 3(1):45-7. PubMed ID: 17035732
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
16. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.
de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE
J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305
[TBL] [Abstract][Full Text] [Related]
17. [The role of sphingolipids in cardiovascular pathologies].
Alessenko AV; Lebedev АТ; Kurochkin IN
Biomed Khim; 2018 Nov; 64(6):487-495. PubMed ID: 30632976
[TBL] [Abstract][Full Text] [Related]
18. Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease.
Chakrabarti SS; Bir A; Poddar J; Sinha M; Ganguly A; Chakrabarti S
Curr Alzheimer Res; 2016; 13(11):1232-1248. PubMed ID: 27335046
[TBL] [Abstract][Full Text] [Related]
19. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
20. The Role of Eicosanoids in Alzheimer's Disease.
Biringer RG
Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
